| Hailun Wang, MD | |
|
21 South Rd Ste 112, Farmington, CT 06032-2482 | |
| (860) 284-4950 | |
| (860) 284-4951 |
| Full Name | Hailun Wang |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 21 South Rd Ste 112, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174815096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD457354 (Pennsylvania) | Secondary |
| 207Y00000X | Otolaryngology | 56771 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital & Medical Center | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Physicians Pc | 1355246950 | 236 |
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability — the likelihood of genetic mutation — is a trait that can itself be favored or disfavored through the process of natural selection.
Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | Prohealth Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720194053 PECOS PAC ID: 1355246950 Enrollment ID: O20031205000602 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability — the likelihood of genetic mutation — is a trait that can itself be favored or disfavored through the process of natural selection.
Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability — the likelihood of genetic mutation — is a trait that can itself be favored or disfavored through the process of natural selection.
Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | Ear Nose & Throat Institute Of Connecticut Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316724891 PECOS PAC ID: 4284078296 Enrollment ID: O20240219000430 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability — the likelihood of genetic mutation — is a trait that can itself be favored or disfavored through the process of natural selection.
Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hailun Wang, MD 21 South Rd, Suite 112, Farmington, CT 06032-2482 Ph: (860) 284-4950 | Hailun Wang, MD 21 South Rd Ste 112, Farmington, CT 06032-2482 Ph: (860) 284-4950 |
News Archive
Low baseline diastolic blood pressure appears to be associated with brain atrophy in patients with arterial disease, whenever declining levels of blood pressure over time among patients who had a higher baseline BP were associated with less progression of atrophy, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.
That's the conclusion drawn by two Rice University scientists who have designed a computer simulation to test the idea that evolvability — the likelihood of genetic mutation — is a trait that can itself be favored or disfavored through the process of natural selection.
Cancer researchers are constantly in search of more-effective and less-toxic approaches to stopping the disease, and have recently launched clinical trials testing a new class of drugs called BET inhibitors. These therapies act on a group of proteins that help regulate the expression of many genes, some of which play a role in cancer.
U.S. Physical Therapy, Inc., a national operator of outpatient physical therapy clinics, today reported results for the fourth quarter and year ended December 31, 2011.
› Verified 6 days ago
Nicholas Stephen Karter, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 499 Farmington Ave, Farmington, CT 06032 Phone: 860-676-2472 Fax: 860-678-9119 | |
Dr. Daniel Stewart Roberts, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Uconn Medical Group, 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-2804 Fax: 860-679-1848 | |
Kimberley D Rutherford, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 599 Farmington Ave Ste 102, Farmington, CT 06032 Phone: 860-284-4950 Fax: 860-284-4951 | |
Belachew Tessema, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21 South Rd, Farmington, CT 06032 Phone: 860-284-4950 | |
Kourosh Parham, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2804 Fax: 860-679-1848 | |
Dr. Brook M. Seeley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 499 Farmington Ave., Suite 210, Farmington, CT 06030 Phone: 860-676-2472 Fax: 860-678-9119 |